Seven Former FDA Commissioners: The FDA Should Be An Independent Federal Agency.

Biomedical Research Decision Making Humans United States United States Dept. of Health and Human Services / organization & administration United States Food and Drug Administration / legislation & jurisprudence

Journal

Health affairs (Project Hope)
ISSN: 1544-5208
Titre abrégé: Health Aff (Millwood)
Pays: United States
ID NLM: 8303128

Informations de publication

Date de publication:
01 2019
Historique:
entrez: 8 1 2019
pubmed: 8 1 2019
medline: 6 8 2019
Statut: ppublish

Résumé

Seven former commissioners of the Food and Drug Administration (FDA) from both sides of the political aisle recommend that the FDA be moved out of the Department of Health and Human Services and reconfigured as an independent federal agency. We believe that such a reengineering would promote reliance on consistent science-based regulation and ensure that the American public has access to the best that science and industry can offer.

Identifiants

DOI: 10.1377/hlthaff.2018.05185 PMID: 30615515
pubmed: 30615515
doi: 10.1377/hlthaff.2018.05185
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Pagination

84-86

Auteurs

Robert M Califf (RM)

Robert M. Califf is the Donald F. Fortin, M.D. Professor of Cardiology at the Duke University School of Medicine, in Durham, North Carolina. Dr. Califf was FDA commissioner from 2016 to 2017.

Margaret Hamburg (M)

Margaret Hamburg is foreign secretary of the National Academy of Medicine and president of the American Association for the Advancement of Science, in Washington, D.C. Dr. Hamburg was FDA commissioner from 2009 to 2015.

Jane E Henney (JE)

Jane E. Henney is home secretary of the National Academy of Medicine, in Washington, D.C. Dr. Henney was FDA commissioner from 1998 to 2001.

David A Kessler (DA)

David A. Kessler is a professor of pediatrics and of epidemiology and biostatistics at the University of California San Francisco. Dr. Kessler was FDA commissioner from 1990 to 1997.

Mark McClellan (M)

Mark McClellan is director of the Duke-Robert J. Margolis Center for Health Policy and the Robert J. Margolis Professor of Business, Medicine, and Policy at Duke University, in Durham, North Carolina, and Washington, D.C. Dr. McClellan was FDA commissioner from 2002 to 2004.

Andrew C von Eschenbach (AC)

Andrew C. von Eschenbach is president of Samaritan Health Initiatives, in Montgomery, Texas. Dr. von Eschenbach was FDA commissioner from 2006 to 2009.

Frank Young (F)

Frank Young is executive vice president of clinical and regulatory affairs at TissueTech, Inc., and Subsidiaries, in Miami, Florida. Dr. Young was FDA commissioner from 1984 to 1989.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Disciplines des sciences naturelles › Science › Recherche › Recherche biomédicale › Seven Former FDA Commissioners: The FDA Should...
questionsmedicales.fr › Phénomènes psychologiques › Processus mentaux › Pensée (activité mentale) › Prise de décision › Seven Former FDA Commissioners: The FDA Should...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Seven Former FDA Commissioners: The FDA Should...
questionsmedicales.fr › Régions géographiques › Amériques › Amérique du Nord › États-Unis › Seven Former FDA Commissioners: The FDA Should...
questionsmedicales.fr › Organisations et économie des soins de santé › Organismes › Gouvernement › Agences gouvernementale américaines › Department of Health and Human Services (USA) › Seven Former FDA Commissioners: The FDA Should...
questionsmedicales.fr › Organisations et économie des soins de santé › Organismes › Gouvernement › Agences gouvernementale américaines › Department of Health and Human Services (USA) › Public Health Service (USA) › Food and Drug Administration (USA) › Seven Former FDA Commissioners: The FDA Should...